Blog

Yttrium-90 Therapy for Liver Cancer Patients

A very exciting new medical breakthrough for the treatment of liver cancer patients, Yttrium-90 (Y-90), is rapidly becoming a palliative measure used to prolong the time to progression and survival of patients with Hepatocellular Carcinoma (HCC) or liver tumors from metastatic colorectal carcinoma.

For patients with HCC, he results have been very promising, often showing better results than chemotherapy and sometimes completely killing smaller tumors*.

Radiology and Imaging Consultants is one of three or four facilities in Colorado offering this treatment and proudly has two physicians who perform this procedure: Dr. Steven Wegert and Dr. J. Werner Ziegler.

To learn more about Y-90, please read this exciting interview by Dr. Wegert courtesy of Medical Voyce’s Healthy Coloradoan.

Yttrium-90 |Radioembolization Offers New Hope To Patients With Liver Cancer

 

References:

Salem, Riad, M.D., M.B.A, and Daniel E. Wertman, M.D. “90Y Radioembolization Is Safe, Effective Liver Cancer Treatment.” 90Y Radioembolization Is Safe, Effective Liver Cancer Treatment. RSNA, 1 Aug. 2011. Web. 02 Nov. 2012. <http://www.rsna.org/NewsDetail.aspx?id=1914>.